Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Brachytherapy × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 49 Neoplasms 3 Radiation Injuries 2 Uterine Cervical Neoplasms 1 Recurrence 1 Prostatic Diseases 1 Prostate Cancer With Intermediate Risk 1 Melanoma 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Directly Observed Therapy 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 5 Nivolumab 5 Cyclophosphamide 4 fludarabine phosphate 3 Mycophenolic Acid 3 Gemcitabine 3 Filgrastim 3 Cisplatin 3 Carboplatin 3 cabazitaxel 2 Whole-Body Irradiation 2 Therapeutics 2 Standard of Care 2 Sirolimus 2 Radiotherapy 2 Polymerase Chain Reaction 2 Mitomycin 2 Methylprednisolone 2 Methotrexate 2 Goserelin 2 Flow Cytometry 2 Cyclosporine 2 Cetuximab 2 Busulfan 2 Antilymphocyte Serum 2 thymoglobulin 1 temsirolimus 1 sargramostim 1 osunprotafib 1 motexafin gadolinium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05715502 2025-04-30

FocaSaBra

The Greater Poland Cancer Centre

Phase NA Recruiting

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡